RedHill Biopharma reported $4.62M in Cash and Equivalent for its fiscal quarter ending in December of 2024.


Cash And Equivalent Change Date
Clal Biotechnology ILS 5.73M 1.71M Dec/2023
Compugen USD 6.47M 11.76M Jun/2025
Cronos Group USD 794.42M 3.4M Jun/2025
RedHill Biopharma USD 4.62M 2.66M Dec/2024